(Q39341881)

English

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine

scientific article published on January 2007

Statements

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit